Nirmatrelvir-ritonavir no aid for long COVID symptoms
Jun 10, 2024
The findings based on symptoms at 10 weeks following 15-day course in vaccinated cohort.
ACC: Bempedoic acid cuts cardiovascular event risk in statin-intolerant
Mar 06, 2023
Those receiving bempedoic acid had a greater reduction in LDL cholesterol and significantly lower incidence of composite of major adverse cardiovascular events.
Few excess deaths seen in Massachusetts during omicron surge
Aug 25, 2022
The uncoupling of excess mortality from new COVID-19 cases was observed during a spring 2022 surge in the highly vaccinated state of Massachusetts.
Vigorous physical activity linked to lower mortality
Nov 04, 2022
And, increasing intensity for a given amount of physical activity is associated with reduction in cardiovascular disease.
Number of homebound older adults up in 2020
Sep 08, 2021
In 2020, the proportion of community-dwelling, homebound older adults substantially increased, according to a research letter published online Aug. 23 in JAMA Internal Medicine.
Paxlovid soon will not be free for Americans
Dec 07, 2022
At this point, about 6 million Americans have taken free Paxlovid doses.
AAN updates guideline for treatment of painful diabetic neuropathy
Dec 30, 2021
When patients do not experience meaningful improvement with the initial therapeutic class, medication from a different class should be offered.
Higher dose of steroid does not improve outcomes in severe COVID-19
Oct 29, 2021
The number of days alive without life support at day 28 did not differ with dexamethasone 12 mg versus 6 mg in those with severe hypoxemia.
Itepekimab bests placebo for moderate-to-severe asthma
Oct 28, 2021
The incidence of events indicating a loss of asthma control was lower with itepekimab monotherapy in a phase 2, proof-of-concept trial.
ASA: Nearly one in five people develop dementia after stroke
Feb 08, 2024
In the first year after stroke, there is an almost threefold higher risk for dementia.